.Merck trumps earnings requirements, raises purchases overview on strong need for best medications like Keytruda CNBCMerck & Co. (MRK US) Defeats Earnings Estimates as Keytruda Purchases Increase BloombergMerck Supply: Pharma Giant Posts Tough Outcomes, However Outlook Falls Short Capitalist's Company DailyMerck Announces Second-Quarter 2024 Financial End results Yahoo FinanceMerck trumps income as well as purchases expectations surrounded by Keytruda advantage, yet gives blended full-year expectation MarketWatch.